These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 23602852)

  • 1. Molecular virology of chronic hepatitis B and C: parallels, contrasts and impact on drug development and treatment outcome.
    Delaney WE
    Antiviral Res; 2013 Jul; 99(1):34-48. PubMed ID: 23602852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the pathogenesis and management of hepatitis B/HIV and hepatitis B/hepatitis C virus coinfection.
    Cheruvu S; Marks K; Talal AH
    Clin Liver Dis; 2007 Nov; 11(4):917-43, ix-x. PubMed ID: 17981235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
    Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
    Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W; Al-Nakib W
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genotype distribution of chronic hepatitis B and hepatitis C patients and investigation of the resistance patterns in hepatitis B cases].
    Kalayci R; Altindiş M; Gülamber G; Demirtürk N; Akcan Y; Demirdal T
    Mikrobiyol Bul; 2010 Apr; 44(2):237-43. PubMed ID: 20549958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chronic hepatitis B or C in HIV-infected patients with dual viral hepatitis.
    Soriano V; Barreiro P; Martín-Carbonero L; Castellares C; Ruiz-Sancho A; Labarga P; Ramos B; Gonzalez-Lahoz J
    J Infect Dis; 2007 Apr; 195(8):1181-3. PubMed ID: 17357055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of replication of hepatitis B and C virus improves patient and graft survival in kidney transplantation.
    Fontaine H; Alric L; Labreuche J; Legendre B; Louvet A; Antoine C; Legendre CM; Hazzan M; Kamar N; Dharancy S; Pol S; Duhamel A; Mathurin P
    J Hepatol; 2019 May; 70(5):831-838. PubMed ID: 30879789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus and hepatitis C virus treatment and management in patients receiving immune-modifying agents.
    Juan J; Feld JJ
    Curr Opin Rheumatol; 2014 Jul; 26(4):395-403. PubMed ID: 24841230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of dual infection of hepatitis B and C viruses among patients with chronic liver disease: a study from tertiary care hospital.
    Chakravarti A; Verma V; Jain M; Kar P
    Trop Gastroenterol; 2005; 26(4):183-7. PubMed ID: 16737047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B and C viral load changes following initiation of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection.
    Asmuth DM; Busch MP; Laycock ME; Mohr BA; Kalish LA; van der Horst CM;
    Antiviral Res; 2004 Aug; 63(2):123-31. PubMed ID: 15302141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical examinations based on nucleic acids of hepatitis viruses].
    Tanaka Y; Mizokami M
    Rinsho Byori; 2006 Nov; 54(11):1164-71. PubMed ID: 17240839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major causes of antiviral drug resistance and implications for treatment of hepatitis B virus monoinfection and coinfection with HIV.
    Locarnini S; Warner N
    Antivir Ther; 2007; 12 Suppl 3():H15-23. PubMed ID: 18284179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symbiotic chemo- and immuno-therapy for hepatitis B and C viruses.
    Agrawal B; Kumar R
    World J Gastroenterol; 2016 Jul; 22(25):5623-6. PubMed ID: 27433078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics methods for the analysis of hepatitis viruses.
    Moriconi F; Beard MR; Yuen LK
    Antivir Ther; 2013; 18(3 Pt B):531-9. PubMed ID: 23792814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virological profiles in patients with chronic hepatitis C and overt or occult HBV infection.
    Squadrito G; Orlando ME; Pollicino T; Raffa G; Restuccia T; Cacciola I; Di Marco V; Picciotto A; Colucci G; Craxì A; Raimondo G
    Am J Gastroenterol; 2002 Jun; 97(6):1518-23. PubMed ID: 12094876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatotropic viruses: new insights in pathogenesis and treatment.
    Gatta A; Giannini C; Lampertico P; Pontisso P; Quarta S; Zignego AL; Atzeni F; Sarzi-Puttini P
    Clin Exp Rheumatol; 2008; 26(1 Suppl 48):S33-8. PubMed ID: 18570752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection.
    Hofmann WP; Soriano V; Zeuzem S
    Handb Exp Pharmacol; 2009; (189):321-46. PubMed ID: 19048206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Monitoring patients with chronic hepatitis during and after therapy].
    Colić-Cvrlje V; Mise S
    Acta Med Croatica; 2009 Dec; 63(5):377-83. PubMed ID: 20198895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular virology of hepatitis B virus and targets for antiviral intervention.
    Glebe D; König A
    Intervirology; 2014; 57(3-4):134-40. PubMed ID: 25034480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral therapy of chronic hepatitis B: prevention of drug resistance.
    Fournier C; Zoulim F
    Clin Liver Dis; 2007 Nov; 11(4):869-92, ix. PubMed ID: 17981233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.